6.80
+6.48(+2000.00%)
Currency In EUR
Address
Hemmelrather Weg 201
Leverkusen, 51377
Germany
Phone
49 214 87 63 2 0
Website
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
91
First IPO Date
October 31, 2006
| Name | Title | Pay | Year Born |
| Ms. Pilar de la Huerta Martinez | Chief Financial Officer & Member of Executive Board | 369,000 | 1969 |
| Mr. Ludwig M. Lutter | Member of the Executive Board | 435,646 | 1967 |
| Dr. Montserrat Foguet Ph.D. | Managing Director of Biofrontera UK Ltd. | 0 | N/A |
| Dr. Matthias Naumann | Head of Sales & Marketing - Europe | 0 | N/A |
| Mr. Alexander Richardson | Head of UK Sales Team | 0 | N/A |
Biofrontera AG, a biopharmaceutical company, engages in the research, development, and marketing of dermatological products. Its products include Ameluz and BF-RhodoLED lamp for the treatment of mild and moderate actinic keratoses on the face and scalp, field cancerization, and fatal squamous cell carcinoma. The company also develops RhodoLED XL for the treatment of multiple interspersed lesions; Belixos, a modern active cosmetic product for irritated and sensitive skin; and Xepi for the treatment of antibiotic-resistant bacteria. It offers its products primarily in the United States, Europe, and Israel. The company has a collaboration and partnership agreement with Maruho Co., Ltd. Biofrontera AG was founded in 1997 and is headquartered in Leverkusen, Germany.
